 | • レポートコード：MRC2Q12-18799 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、0.9%塩化ナトリウム点滴注射のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 0.9%塩化ナトリウム点滴注射のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 0.9%塩化ナトリウム点滴注射の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 0.9%塩化ナトリウム点滴注射のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの0.9%塩化ナトリウム点滴注射の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の0.9%塩化ナトリウム点滴注射の売上および2028年までの予測に焦点を当てています。 0.9%塩化ナトリウム点滴注射のグローバル主要企業には、Kelun Group、Baxter、Fresenius Kabi、Shijiazhuang No.4 Pharmaceutical、CR Double-Crane、BBraun、Otsuka、Cisen Pharmaceutical、Hospira (ICU Medical)、Huaren Pharmaceuticals、Zhejiang Chimin、Dubang Pharmaceutical、Guizhou Tiandi、Qidu Pharmaceuticalなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 0.9%塩化ナトリウム点滴注射市場は、タイプとアプリケーションによって区分されます。世界の0.9%塩化ナトリウム点滴注射市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 軟質バッグ、ペットボトル、ガラス瓶 【アプリケーション別セグメント】 病院、診療所、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 0.9%塩化ナトリウム点滴注射製品概要 - タイプ別市場（軟質バッグ、ペットボトル、ガラス瓶） - アプリケーション別市場（病院、診療所、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の0.9%塩化ナトリウム点滴注射販売量予測2017-2028 - 世界の0.9%塩化ナトリウム点滴注射売上予測2017-2028 - 0.9%塩化ナトリウム点滴注射の地域別販売量 - 0.9%塩化ナトリウム点滴注射の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別0.9%塩化ナトリウム点滴注射販売量 - 主要メーカー別0.9%塩化ナトリウム点滴注射売上 - 主要メーカー別0.9%塩化ナトリウム点滴注射価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（軟質バッグ、ペットボトル、ガラス瓶） - 0.9%塩化ナトリウム点滴注射のタイプ別販売量 - 0.9%塩化ナトリウム点滴注射のタイプ別売上 - 0.9%塩化ナトリウム点滴注射のタイプ別価格 ・アプリケーション別市場規模（病院、診療所、その他） - 0.9%塩化ナトリウム点滴注射のアプリケーション別販売量 - 0.9%塩化ナトリウム点滴注射のアプリケーション別売上 - 0.9%塩化ナトリウム点滴注射のアプリケーション別価格 ・北米市場 - 北米の0.9%塩化ナトリウム点滴注射市場規模（タイプ別、アプリケーション別） - 主要国別の0.9%塩化ナトリウム点滴注射市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの0.9%塩化ナトリウム点滴注射市場規模（タイプ別、アプリケーション別） - 主要国別の0.9%塩化ナトリウム点滴注射市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の0.9%塩化ナトリウム点滴注射市場規模（タイプ別、アプリケーション別） - 主要国別の0.9%塩化ナトリウム点滴注射市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の0.9%塩化ナトリウム点滴注射市場規模（タイプ別、アプリケーション別） - 主要国別の0.9%塩化ナトリウム点滴注射市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの0.9%塩化ナトリウム点滴注射市場規模（タイプ別、アプリケーション別） - 主要国別の0.9%塩化ナトリウム点滴注射市場規模（トルコ、サウジアラビア） ・企業情報 Kelun Group、Baxter、Fresenius Kabi、Shijiazhuang No.4 Pharmaceutical、CR Double-Crane、BBraun、Otsuka、Cisen Pharmaceutical、Hospira (ICU Medical)、Huaren Pharmaceuticals、Zhejiang Chimin、Dubang Pharmaceutical、Guizhou Tiandi、Qidu Pharmaceutical ・産業チェーン及び販売チャネル分析 - 0.9%塩化ナトリウム点滴注射の産業チェーン分析 - 0.9%塩化ナトリウム点滴注射の原材料 - 0.9%塩化ナトリウム点滴注射の生産プロセス - 0.9%塩化ナトリウム点滴注射の販売及びマーケティング - 0.9%塩化ナトリウム点滴注射の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 0.9%塩化ナトリウム点滴注射の産業動向 - 0.9%塩化ナトリウム点滴注射のマーケットドライバー - 0.9%塩化ナトリウム点滴注射の課題 - 0.9%塩化ナトリウム点滴注射の阻害要因 ・主な調査結果 |
0.9% sodium chloride water, also called as normal saline. It is a colorless, clear liquid. And it is sterile and no pyrogenic.
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for 0.9% Sodium Chloride Intravenous Infusion is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for 0.9% Sodium Chloride Intravenous Infusion is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for 0.9% Sodium Chloride Intravenous Infusion is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of 0.9% Sodium Chloride Intravenous Infusion include Kelun Group, Baxter, Fresenius Kabi, Shijiazhuang No.4 Pharmaceutical, CR Double-Crane, BBraun, Otsuka, Cisen Pharmaceutical and Hospira (ICU Medical), etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the 0.9% Sodium Chloride Intravenous Infusion manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional 0.9% Sodium Chloride Intravenous Infusion market. Further, it explains the major drivers and regional dynamics of the global 0.9% Sodium Chloride Intravenous Infusion market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Kelun Group
Baxter
Fresenius Kabi
Shijiazhuang No.4 Pharmaceutical
CR Double-Crane
BBraun
Otsuka
Cisen Pharmaceutical
Hospira (ICU Medical)
Huaren Pharmaceuticals
Zhejiang Chimin
Dubang Pharmaceutical
Guizhou Tiandi
Qidu Pharmaceutical
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
0.9% Sodium Chloride Intravenous Infusion Segment by Type
Flexible Bag
Plastic Bottles
Glass Bottle
0.9% Sodium Chloride Intravenous Infusion Segment by Application
Hospitals
Clinics
Other
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the 0.9% Sodium Chloride Intravenous Infusion market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for 0.9% Sodium Chloride Intravenous Infusion, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of 0.9% Sodium Chloride Intravenous Infusion, also provides the sales of main regions and countries. Highlights of the upcoming market potential for 0.9% Sodium Chloride Intravenous Infusion, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the 0.9% Sodium Chloride Intravenous Infusion sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global 0.9% Sodium Chloride Intravenous Infusion market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for 0.9% Sodium Chloride Intravenous Infusion sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Kelun Group, Baxter, Fresenius Kabi, Shijiazhuang No.4 Pharmaceutical, CR Double-Crane, BBraun, Otsuka, Cisen Pharmaceutical and Hospira (ICU Medical), etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of 0.9% Sodium Chloride Intravenous Infusion in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of 0.9% Sodium Chloride Intravenous Infusion manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, 0.9% Sodium Chloride Intravenous Infusion sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 0.9% Sodium Chloride Intravenous Infusion Product Introduction
1.2 Market by Type
1.2.1 Global 0.9% Sodium Chloride Intravenous Infusion Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Flexible Bag
1.2.3 Plastic Bottles
1.2.4 Glass Bottle
1.3 Market by Application
1.3.1 Global 0.9% Sodium Chloride Intravenous Infusion Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global 0.9% Sodium Chloride Intravenous Infusion Sales Estimates and Forecasts 2017-2028
2.2 Global 0.9% Sodium Chloride Intravenous Infusion Revenue Estimates and Forecasts 2017-2028
2.3 Global 0.9% Sodium Chloride Intravenous Infusion Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global 0.9% Sodium Chloride Intravenous Infusion Sales by Region
2.4.1 Global 0.9% Sodium Chloride Intravenous Infusion Sales by Region (2017-2022)
2.4.2 Global Sales 0.9% Sodium Chloride Intravenous Infusion by Region (2023-2028)
2.5 Global 0.9% Sodium Chloride Intravenous Infusion Revenue by Region
2.5.1 Global 0.9% Sodium Chloride Intravenous Infusion Revenue by Region (2017-2022)
2.5.2 Global 0.9% Sodium Chloride Intravenous Infusion Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global 0.9% Sodium Chloride Intravenous Infusion Sales by Manufacturers
3.1.1 Global Top 0.9% Sodium Chloride Intravenous Infusion Manufacturers by Sales (2017-2022)
3.1.2 Global 0.9% Sodium Chloride Intravenous Infusion Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of 0.9% Sodium Chloride Intravenous Infusion in 2021
3.2 Global 0.9% Sodium Chloride Intravenous Infusion Revenue by Manufacturers
3.2.1 Global 0.9% Sodium Chloride Intravenous Infusion Revenue by Manufacturers (2017-2022)
3.2.2 Global 0.9% Sodium Chloride Intravenous Infusion Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by 0.9% Sodium Chloride Intravenous Infusion Revenue in 2021
3.3 Global 0.9% Sodium Chloride Intravenous Infusion Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global 0.9% Sodium Chloride Intravenous Infusion Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global 0.9% Sodium Chloride Intravenous Infusion Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global 0.9% Sodium Chloride Intravenous Infusion Sales by Type
4.1.1 Global 0.9% Sodium Chloride Intravenous Infusion Historical Sales by Type (2017-2022)
4.1.2 Global 0.9% Sodium Chloride Intravenous Infusion Forecasted Sales by Type (2023-2028)
4.1.3 Global 0.9% Sodium Chloride Intravenous Infusion Sales Market Share by Type (2017-2028)
4.2 Global 0.9% Sodium Chloride Intravenous Infusion Revenue by Type
4.2.1 Global 0.9% Sodium Chloride Intravenous Infusion Historical Revenue by Type (2017-2022)
4.2.2 Global 0.9% Sodium Chloride Intravenous Infusion Forecasted Revenue by Type (2023-2028)
4.2.3 Global 0.9% Sodium Chloride Intravenous Infusion Revenue Market Share by Type (2017-2028)
4.3 Global 0.9% Sodium Chloride Intravenous Infusion Price by Type
4.3.1 Global 0.9% Sodium Chloride Intravenous Infusion Price by Type (2017-2022)
4.3.2 Global 0.9% Sodium Chloride Intravenous Infusion Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global 0.9% Sodium Chloride Intravenous Infusion Sales by Application
5.1.1 Global 0.9% Sodium Chloride Intravenous Infusion Historical Sales by Application (2017-2022)
5.1.2 Global 0.9% Sodium Chloride Intravenous Infusion Forecasted Sales by Application (2023-2028)
5.1.3 Global 0.9% Sodium Chloride Intravenous Infusion Sales Market Share by Application (2017-2028)
5.2 Global 0.9% Sodium Chloride Intravenous Infusion Revenue by Application
5.2.1 Global 0.9% Sodium Chloride Intravenous Infusion Historical Revenue by Application (2017-2022)
5.2.2 Global 0.9% Sodium Chloride Intravenous Infusion Forecasted Revenue by Application (2023-2028)
5.2.3 Global 0.9% Sodium Chloride Intravenous Infusion Revenue Market Share by Application (2017-2028)
5.3 Global 0.9% Sodium Chloride Intravenous Infusion Price by Application
5.3.1 Global 0.9% Sodium Chloride Intravenous Infusion Price by Application (2017-2022)
5.3.2 Global 0.9% Sodium Chloride Intravenous Infusion Price Forecast by Application (2023-2028)
6 North America
6.1 North America 0.9% Sodium Chloride Intravenous Infusion Market Size by Type
6.1.1 North America 0.9% Sodium Chloride Intravenous Infusion Sales by Type (2017-2028)
6.1.2 North America 0.9% Sodium Chloride Intravenous Infusion Revenue by Type (2017-2028)
6.2 North America 0.9% Sodium Chloride Intravenous Infusion Market Size by Application
6.2.1 North America 0.9% Sodium Chloride Intravenous Infusion Sales by Application (2017-2028)
6.2.2 North America 0.9% Sodium Chloride Intravenous Infusion Revenue by Application (2017-2028)
6.3 North America 0.9% Sodium Chloride Intravenous Infusion Market Size by Country
6.3.1 North America 0.9% Sodium Chloride Intravenous Infusion Sales by Country (2017-2028)
6.3.2 North America 0.9% Sodium Chloride Intravenous Infusion Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe 0.9% Sodium Chloride Intravenous Infusion Market Size by Type
7.1.1 Europe 0.9% Sodium Chloride Intravenous Infusion Sales by Type (2017-2028)
7.1.2 Europe 0.9% Sodium Chloride Intravenous Infusion Revenue by Type (2017-2028)
7.2 Europe 0.9% Sodium Chloride Intravenous Infusion Market Size by Application
7.2.1 Europe 0.9% Sodium Chloride Intravenous Infusion Sales by Application (2017-2028)
7.2.2 Europe 0.9% Sodium Chloride Intravenous Infusion Revenue by Application (2017-2028)
7.3 Europe 0.9% Sodium Chloride Intravenous Infusion Market Size by Country
7.3.1 Europe 0.9% Sodium Chloride Intravenous Infusion Sales by Country (2017-2028)
7.3.2 Europe 0.9% Sodium Chloride Intravenous Infusion Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific 0.9% Sodium Chloride Intravenous Infusion Market Size by Type
8.1.1 Asia Pacific 0.9% Sodium Chloride Intravenous Infusion Sales by Type (2017-2028)
8.1.2 Asia Pacific 0.9% Sodium Chloride Intravenous Infusion Revenue by Type (2017-2028)
8.2 Asia Pacific 0.9% Sodium Chloride Intravenous Infusion Market Size by Application
8.2.1 Asia Pacific 0.9% Sodium Chloride Intravenous Infusion Sales by Application (2017-2028)
8.2.2 Asia Pacific 0.9% Sodium Chloride Intravenous Infusion Revenue by Application (2017-2028)
8.3 Asia Pacific 0.9% Sodium Chloride Intravenous Infusion Market Size by Region
8.3.1 Asia Pacific 0.9% Sodium Chloride Intravenous Infusion Sales by Region (2017-2028)
8.3.2 Asia Pacific 0.9% Sodium Chloride Intravenous Infusion Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America 0.9% Sodium Chloride Intravenous Infusion Market Size by Type
9.1.1 Latin America 0.9% Sodium Chloride Intravenous Infusion Sales by Type (2017-2028)
9.1.2 Latin America 0.9% Sodium Chloride Intravenous Infusion Revenue by Type (2017-2028)
9.2 Latin America 0.9% Sodium Chloride Intravenous Infusion Market Size by Application
9.2.1 Latin America 0.9% Sodium Chloride Intravenous Infusion Sales by Application (2017-2028)
9.2.2 Latin America 0.9% Sodium Chloride Intravenous Infusion Revenue by Application (2017-2028)
9.3 Latin America 0.9% Sodium Chloride Intravenous Infusion Market Size by Country
9.3.1 Latin America 0.9% Sodium Chloride Intravenous Infusion Sales by Country (2017-2028)
9.3.2 Latin America 0.9% Sodium Chloride Intravenous Infusion Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa 0.9% Sodium Chloride Intravenous Infusion Market Size by Type
10.1.1 Middle East and Africa 0.9% Sodium Chloride Intravenous Infusion Sales by Type (2017-2028)
10.1.2 Middle East and Africa 0.9% Sodium Chloride Intravenous Infusion Revenue by Type (2017-2028)
10.2 Middle East and Africa 0.9% Sodium Chloride Intravenous Infusion Market Size by Application
10.2.1 Middle East and Africa 0.9% Sodium Chloride Intravenous Infusion Sales by Application (2017-2028)
10.2.2 Middle East and Africa 0.9% Sodium Chloride Intravenous Infusion Revenue by Application (2017-2028)
10.3 Middle East and Africa 0.9% Sodium Chloride Intravenous Infusion Market Size by Country
10.3.1 Middle East and Africa 0.9% Sodium Chloride Intravenous Infusion Sales by Country (2017-2028)
10.3.2 Middle East and Africa 0.9% Sodium Chloride Intravenous Infusion Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Kelun Group
11.1.1 Kelun Group Corporation Information
11.1.2 Kelun Group Overview
11.1.3 Kelun Group 0.9% Sodium Chloride Intravenous Infusion Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Kelun Group 0.9% Sodium Chloride Intravenous Infusion Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Kelun Group Recent Developments
11.2 Baxter
11.2.1 Baxter Corporation Information
11.2.2 Baxter Overview
11.2.3 Baxter 0.9% Sodium Chloride Intravenous Infusion Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Baxter 0.9% Sodium Chloride Intravenous Infusion Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Baxter Recent Developments
11.3 Fresenius Kabi
11.3.1 Fresenius Kabi Corporation Information
11.3.2 Fresenius Kabi Overview
11.3.3 Fresenius Kabi 0.9% Sodium Chloride Intravenous Infusion Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Fresenius Kabi 0.9% Sodium Chloride Intravenous Infusion Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Fresenius Kabi Recent Developments
11.4 Shijiazhuang No.4 Pharmaceutical
11.4.1 Shijiazhuang No.4 Pharmaceutical Corporation Information
11.4.2 Shijiazhuang No.4 Pharmaceutical Overview
11.4.3 Shijiazhuang No.4 Pharmaceutical 0.9% Sodium Chloride Intravenous Infusion Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Shijiazhuang No.4 Pharmaceutical 0.9% Sodium Chloride Intravenous Infusion Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Shijiazhuang No.4 Pharmaceutical Recent Developments
11.5 CR Double-Crane
11.5.1 CR Double-Crane Corporation Information
11.5.2 CR Double-Crane Overview
11.5.3 CR Double-Crane 0.9% Sodium Chloride Intravenous Infusion Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 CR Double-Crane 0.9% Sodium Chloride Intravenous Infusion Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 CR Double-Crane Recent Developments
11.6 BBraun
11.6.1 BBraun Corporation Information
11.6.2 BBraun Overview
11.6.3 BBraun 0.9% Sodium Chloride Intravenous Infusion Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 BBraun 0.9% Sodium Chloride Intravenous Infusion Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 BBraun Recent Developments
11.7 Otsuka
11.7.1 Otsuka Corporation Information
11.7.2 Otsuka Overview
11.7.3 Otsuka 0.9% Sodium Chloride Intravenous Infusion Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Otsuka 0.9% Sodium Chloride Intravenous Infusion Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Otsuka Recent Developments
11.8 Cisen Pharmaceutical
11.8.1 Cisen Pharmaceutical Corporation Information
11.8.2 Cisen Pharmaceutical Overview
11.8.3 Cisen Pharmaceutical 0.9% Sodium Chloride Intravenous Infusion Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Cisen Pharmaceutical 0.9% Sodium Chloride Intravenous Infusion Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Cisen Pharmaceutical Recent Developments
11.9 Hospira (ICU Medical)
11.9.1 Hospira (ICU Medical) Corporation Information
11.9.2 Hospira (ICU Medical) Overview
11.9.3 Hospira (ICU Medical) 0.9% Sodium Chloride Intravenous Infusion Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Hospira (ICU Medical) 0.9% Sodium Chloride Intravenous Infusion Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Hospira (ICU Medical) Recent Developments
11.10 Huaren Pharmaceuticals
11.10.1 Huaren Pharmaceuticals Corporation Information
11.10.2 Huaren Pharmaceuticals Overview
11.10.3 Huaren Pharmaceuticals 0.9% Sodium Chloride Intravenous Infusion Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Huaren Pharmaceuticals 0.9% Sodium Chloride Intravenous Infusion Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Huaren Pharmaceuticals Recent Developments
11.11 Zhejiang Chimin
11.11.1 Zhejiang Chimin Corporation Information
11.11.2 Zhejiang Chimin Overview
11.11.3 Zhejiang Chimin 0.9% Sodium Chloride Intravenous Infusion Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Zhejiang Chimin 0.9% Sodium Chloride Intravenous Infusion Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Zhejiang Chimin Recent Developments
11.12 Dubang Pharmaceutical
11.12.1 Dubang Pharmaceutical Corporation Information
11.12.2 Dubang Pharmaceutical Overview
11.12.3 Dubang Pharmaceutical 0.9% Sodium Chloride Intravenous Infusion Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Dubang Pharmaceutical 0.9% Sodium Chloride Intravenous Infusion Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Dubang Pharmaceutical Recent Developments
11.13 Guizhou Tiandi
11.13.1 Guizhou Tiandi Corporation Information
11.13.2 Guizhou Tiandi Overview
11.13.3 Guizhou Tiandi 0.9% Sodium Chloride Intravenous Infusion Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Guizhou Tiandi 0.9% Sodium Chloride Intravenous Infusion Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Guizhou Tiandi Recent Developments
11.14 Qidu Pharmaceutical
11.14.1 Qidu Pharmaceutical Corporation Information
11.14.2 Qidu Pharmaceutical Overview
11.14.3 Qidu Pharmaceutical 0.9% Sodium Chloride Intravenous Infusion Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Qidu Pharmaceutical 0.9% Sodium Chloride Intravenous Infusion Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Qidu Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 0.9% Sodium Chloride Intravenous Infusion Industry Chain Analysis
12.2 0.9% Sodium Chloride Intravenous Infusion Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 0.9% Sodium Chloride Intravenous Infusion Production Mode & Process
12.4 0.9% Sodium Chloride Intravenous Infusion Sales and Marketing
12.4.1 0.9% Sodium Chloride Intravenous Infusion Sales Channels
12.4.2 0.9% Sodium Chloride Intravenous Infusion Distributors
12.5 0.9% Sodium Chloride Intravenous Infusion Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 0.9% Sodium Chloride Intravenous Infusion Industry Trends
13.2 0.9% Sodium Chloride Intravenous Infusion Market Drivers
13.3 0.9% Sodium Chloride Intravenous Infusion Market Challenges
13.4 0.9% Sodium Chloride Intravenous Infusion Market Restraints
14 Key Findings in The Global 0.9% Sodium Chloride Intravenous Infusion Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer